<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Diseases of the central <z:mp ids='MP_0008912'>nervous</z:mp> system are found in patients with severe <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> (HHcy) </plain></SENT>
<SENT sid="1" pm="."><plain>Epidemiological studies show a positive, dose-dependent relationship between mild-to-moderate increases in plasma total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> concentrations (<z:chebi fb="0" ids="17230">Hcy</z:chebi>) and the risk of <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo>, such as <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> or <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>HHcy is a surrogate marker for B <z:e sem="disease" ids="C1510471" disease_type="Disease or Syndrome" abbrv="">vitamin deficiency</z:e> (<z:chebi fb="3" ids="37445">folate</z:chebi>, <z:chebi fb="13" ids="33611">B12</z:chebi>, B6) and a <z:chebi fb="0" ids="50910">neurotoxic agent</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>The concept of improving the patient's clinical outcome by lowering of <z:chebi fb="0" ids="17230">Hcy</z:chebi> with B vitamins seems to be attractive </plain></SENT>
<SENT sid="4" pm="."><plain>Recent B vitamin supplementation trials demonstrated a slowing of brain <z:mpath ids='MPATH_127'>atrophy</z:mpath> and improvement in some domains of cognitive function </plain></SENT>
<SENT sid="5" pm="."><plain>Meta-analysis of secondary prevention trials showed that B vitamins supplementation caused a decrease in plasma <z:chebi fb="0" ids="17230">Hcy</z:chebi> and a trend for lowering the risk of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>HHcy is common in elderly people </plain></SENT>
<SENT sid="7" pm="."><plain>Therefore, it seems prudent to identify B vitamin deficient subjects and to ensure sufficient vitamin intake </plain></SENT>
<SENT sid="8" pm="."><plain>Therefore, recent evidence supports the role of <z:chebi fb="0" ids="17230">Hcy</z:chebi> as a potential biomarker in age-related <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo> </plain></SENT>
</text></document>